Sophie Bustany

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells.

Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells.

Journal: Scientific reports

Published: May 15, 2017

Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells.

Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells.

Journal: Oncotarget

Published: February 01, 2016

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.

Journal: Journal of hematology & oncology

Published: February 25, 2015

Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathway.

Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathway.

Journal: BMC cancer

Published: November 27, 2014

Expression and subcellular localization of cyclin-dependent kinase inhibitor p27 does not correlate with proliferation pattern of mantle lymphoma cells.

Expression and subcellular localization of cyclin-dependent kinase inhibitor p27 does not correlate with proliferation pattern of mantle lymphoma cells.

Journal: Leukemia & lymphoma

Published: December 21, 2013

Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.

Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 02, 2013

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism.

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism.

Journal: Oncotarget

Published: August 28, 2013

Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.

Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.

Journal: Cell death & disease

Published: December 21, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026